Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 VIP as a modulator of lung inflammation and airway constriction.

× No keyword cloud information.

10 in total

Review 1. Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors: Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal: Neuromolecular Med Date: 2005 Impact factor: 3.843

2. Characterization of the rat vasoactive intestinal polypeptide receptor gene 5' region.

Authors: L Pei; S Melmed
Journal: Biochem J Date: 1995-06-15 Impact factor: 3.857

3. The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial.

Authors: Jihad Georges Youssef; Philip Lavin; David A Schoenfeld; Richard A Lee; Rainer Lenhardt; David J Park; Javier Perez Fernandez; Melvin L Morganroth; Jonathan C Javitt; Dushyantha Jayaweera
Journal: Crit Care Med Date: 2022-08-29 Impact factor: 9.296

4. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.

Authors: G Ciabattoni; P Montuschi; D Currò; G Togna; P Preziosi
Journal: Br J Pharmacol Date: 1993-05 Impact factor: 8.739

5. Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells.

Authors: S Fujieda; J A Waschek; K Zhang; A Saxon
Journal: J Clin Invest Date: 1996-10-01 Impact factor: 14.808

6. Catalytic activity of anti-ground state antibodies, antibody subunits, and human autoantibodies.

Authors: S Paul
Journal: Appl Biochem Biotechnol Date: 1994 May-Jun Impact factor: 2.926

7. Lung infection caused by Pseudomonas aeruginosa in a CD26/DPP4 deficient F344 rat model.

Authors: M Neuhaus; A Munder; J Schipke; A Schmiedl
Journal: Inflamm Res Date: 2019-05-14 Impact factor: 4.575

8. Brief Report: Rapid Clinical Recovery From Critical Coronavirus Disease 2019 With Respiratory Failure in a Pregnant Patient Treated With IV Vasoactive Intestinal Peptide.

Authors: Jihad Georges Youssef; Mohammad Z Bitar; Faisal Zahiruddin; Mukhtar Al-Saadi; Mahmoud Elshawwaf; Simon Yau; Ahmad Goodarzi; Jonathan C Javitt
Journal: Crit Care Explor Date: 2022-01-05

9. Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.

Authors: Maria Boesing; Kristin Abig; Michael Brändle; Martin Brutsche; Emanuel Burri; Björn C Frye; Stéphanie Giezendanner; Jan C Grutters; Philippe Haas; Justian Heisler; Fabienne Jaun; Anne B Leuppi-Taegtmeyer; Giorgia Lüthi-Corridori; Joachim Müller-Quernheim; Reto Nüesch; Wolfgang Pohl; Frank Rassouli; Jörg D Leuppi
Journal: Trials Date: 2022-09-20 Impact factor: 2.728

10. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.

Authors: Andrew D Foey; Sarah Field; Salman Ahmed; Abhilash Jain; Marc Feldmann; Fionula M Brennan; Richard Williams
Journal: Arthritis Res Ther Date: 2003-09-03 Impact factor: 5.156

10 in total